LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...
LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear expects full-year earnings to be at the lower end of guidance, and has written down the value of its investment in Saluda.
Cochlear's HY26 saw profit decline and steady dividends, as Nexa implant rollout supports second-half growth plans. The post Cochlear posts modest sales growth but lower profit as Nexa launch ...
Morgans has given its verdict on these shares this week. The post What is Morgans saying about Cochlear, Deep Yellow, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results